.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Moodys
Teva
Cerilliant
Fish and Richardson
Harvard Business School
Cipla
UBS
Boehringer Ingelheim
Healthtrust

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,964,212

« Back to Dashboard

Which drugs does patent 7,964,212 protect, and when does it expire?


Patent 7,964,212 protects BINOSTO and is included in one NDA.

This patent has ten patent family members in seven countries.

Summary for Patent: 7,964,212

Title:Effervescent compositions comprising phosphonates and methods related thereto
Abstract: The invention provides effervescent composition comprising a bisphosphonate, an acidic compound, an alkaline effervescing component, and optionally an anti-ulcer agent and methods of treating osteoporosis in a mammal using the effervescent compositions.
Inventor(s): Rosen; Christer (Jupiter, FL)
Assignee:
Application Number:12/367,928
Patent Claim Types:
see list of patent claims
Composition; Formulation;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Mission PharmaBINOSTOalendronate sodiumTABLET, EFFERVESCENT;ORAL202344-001Mar 12, 2012RXYesYes► Subscribe► Subscribe► SubscribeYY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 7,964,212

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,488,496Effervescent compositions comprising bisphosphonates and methods related thereto► Subscribe
8,449,906Effervescent compositions comprising phosphonates and methods related thereto► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 7,964,212

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Spain2448501► Subscribe
Spain2380924► Subscribe
European Patent Office2277503► Subscribe
European Patent Office1490024► Subscribe
Denmark1490024► Subscribe
Canada2495886► Subscribe
Australia2003284275► Subscribe
Australia2003219999► Subscribe
Austria541575► Subscribe
World Intellectual Property Organization (WIPO)03075884► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
McKinsey
Medtronic
Covington
AstraZeneca
Dow
Cipla
Farmers Insurance
Cerilliant
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot